No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Friday, October 31, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Startups

Amsterdam’s Avidicure exits stealth mode with €43.8M to develop new antibody therapies

by TheAdviserMagazine
6 months ago
in Startups
Reading Time: 2 mins read
A A
Amsterdam’s Avidicure exits stealth mode with €43.8M to develop new antibody therapies
Share on FacebookShare on TwitterShare on LInkedIn


Based out of Amsterdam,  Avidicure, a biotechnology company, announced its launch with $50M (approximately €43.8M) in a seed financing round led by EQT Life Sciences.

Additional investors, including Kurma Partners, BioGeneration Ventures, BOM, Curie Capital, and V-Bio Ventures,  also participated in the round.

Avidicure: Developing multifunctional antibody modality to treat cancer

Led by Arthur Lahr, Avidicure is developing dual agonistic, multifunctional, and avidity-engineered antibodies, “AVC-Boosters”, that can safely deliver targeted and potent cancer monotherapy.

The AVC-Booster design surpasses the best qualities of first-generation antibodies, checkpoint inhibitors, T-cell engagers, and antibody-drug conjugates (ADCs). 

“AVC-Boosters have the potential to change the treatment landscape for a wide range of cancers as first-in-class multifunctional antibody products that safely mobilize the full power of the immune system,” says Arthur Lahr, Chief Executive Officer of Avidicure.

“Our products drive targeted and potent immune responses only in the tumor with reduced toxicity risk. We are eager to build a broad pipeline with our unique platform and progress our lead oncology product, AVC-S-101, into clinical development for solid tumors,” adds Lahr.

With the AVC-Booster plug-and-play functionality, multiple products can be developed, claims the company.  

Avidicure’s lead product, AVC-S-101, is a TROP2-targeting booster that is being developed for non-small cell lung cancer and multiple other indications. 

“Avidicure is taking an entirely new approach with broad clinical potential,” says Dr. Joern-Peter Halle, former Chief Strategy Officer and Global Head of Research at Merck KGaA and Chairman of Avidicure’s Scientific Advisory Board.

“Avidicure’s multifunctional antibodies provide a novel treatment modality with a unique, differentiated mode of action. These products are well-positioned to make a significant impact in the treatment of cancer patients,” adds Halle.

The company plans to present its preclinical data at the upcoming American Association for Cancer Research (AACR) Annual Meeting in April and at the American Society of Clinical Oncology (ASCO) Annual Meeting in May.

Founding management team 

The company’s founding management team consists of Arthur Lahr (CEO), Dirk De Naeyer (COO), Robert Friesen (CSO), and Govert Schouten (CBO), who previously served as executive management in Crucell, Ablynx, and Kiadis, and played key roles in the acquisitions of these successful European biotech companies.

The Supervisory Board includes industry veterans Frank Verwiel (Intellia, Aptalis, Bavarian Nordic, Merck & Co.), Martijn Kleijwegt (EQT-LS), Hunter Smith (Rhythm), and Helen Collins (Five Prime, Enliven, Gilead, Amgen).



Source link

Tags: 43.8MAmsterdamsantibodyAvidicuredevelopExitsmodeStealthTherapies
ShareTweetShare
Previous Post

Consumers are so stressed by the economy they’re doing less laundry to save on detergent

Next Post

Hot Stocks KW 17/2025: Die stärksten Aktien nach dem Zoll-Crash!

Related Posts

edit post
Clerq Raises M to Capture Share of T High-Ticket Payment Market – AlleyWatch

Clerq Raises $12M to Capture Share of $3T High-Ticket Payment Market – AlleyWatch

by TheAdviserMagazine
October 30, 2025
0

The shift from physical to digital payments has created a massive divide in the U.S. economy – while consumers routinely...

edit post
Netherlands launches ChipNL Competence Centre to supercharge the Dutch semiconductor sector: Know more 

Netherlands launches ChipNL Competence Centre to supercharge the Dutch semiconductor sector: Know more 

by TheAdviserMagazine
October 30, 2025
0

The ChipNL Competence Centre launches in Eindhoven to boost the Dutch semiconductor industry. It aims to connect companies with facilities,...

edit post
The Prompting Company snags .5M to help products get mentioned in ChatGPT and other AI apps

The Prompting Company snags $6.5M to help products get mentioned in ChatGPT and other AI apps

by TheAdviserMagazine
October 30, 2025
0

People are increasingly asking AI, not Google, to help them discover products. A recent shopping report says Americans, this holiday...

edit post
India’s Snabbit valuation doubled to 0M in 5 months on its quick house-help bet

India’s Snabbit valuation doubled to $180M in 5 months on its quick house-help bet

by TheAdviserMagazine
October 29, 2025
0

India’s appetite for instant convenience — once confined to food and grocery delivery — is expanding into house help. That...

edit post
Building the Foundation for the Future of Services: Inside the York IE Hub

Building the Foundation for the Future of Services: Inside the York IE Hub

by TheAdviserMagazine
October 29, 2025
0

The future of professional services isn’t coming…it’s already here. Artificial intelligence, automation, and data are rewriting the rules of the...

edit post
NVIDIA invests B in Nokia to build AI-powered RAN for the 6G era

NVIDIA invests $1B in Nokia to build AI-powered RAN for the 6G era

by TheAdviserMagazine
October 29, 2025
0

|October 29, 2025|Last update:October 29, 2025Image credits: MuhammadAlimaki/DepositPhotos NVIDIA and Nokia to sign a strategic partnership to enable accelerated development...

Next Post
edit post
Hot Stocks KW 17/2025: Die stärksten Aktien nach dem Zoll-Crash!

Hot Stocks KW 17/2025: Die stärksten Aktien nach dem Zoll-Crash!

edit post
Trump’s WLFI crypto investments aren’t paying off

Trump’s WLFI crypto investments aren’t paying off

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Book Review: Resistance Money: A Philosophical Case for Bitcoin

Book Review: Resistance Money: A Philosophical Case for Bitcoin

0
edit post
ECB October 2025 rate decision

ECB October 2025 rate decision

0
edit post
Goldman Sachs survey says only 11% of companies are actively linking layoffs to AI—but the real shock is yet to come

Goldman Sachs survey says only 11% of companies are actively linking layoffs to AI—but the real shock is yet to come

0
edit post
Has Mastercard accepted the inevitability of crypto? Spends B on tokenization platform

Has Mastercard accepted the inevitability of crypto? Spends $2B on tokenization platform

0
edit post
How to protect your bank account

How to protect your bank account

0
edit post
The 2026 Social Security Bump Will Cost Some Retirees. Are Your Benefits at Risk of Taxation?

The 2026 Social Security Bump Will Cost Some Retirees. Are Your Benefits at Risk of Taxation?

0
edit post
How to protect your bank account

How to protect your bank account

October 31, 2025
edit post
Getting Started: Inventory Types and Conditions

Getting Started: Inventory Types and Conditions

October 31, 2025
edit post
Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)

Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)

October 30, 2025
edit post
Asian shares rise: Asian shares, US futures rise on tech results, gold holds gain

Asian shares rise: Asian shares, US futures rise on tech results, gold holds gain

October 30, 2025
edit post
XRP Could Drive the ‘Biggest Economic Shift’ in Decades: Crypto Expert

XRP Could Drive the ‘Biggest Economic Shift’ in Decades: Crypto Expert

October 30, 2025
edit post
Has Mastercard accepted the inevitability of crypto? Spends B on tokenization platform

Has Mastercard accepted the inevitability of crypto? Spends $2B on tokenization platform

October 30, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • How to protect your bank account
  • Getting Started: Inventory Types and Conditions
  • Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.